These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23905613)

  • 1. Computational properties of η6-toluene and η6-trifluorotoluene half-sandwich Ru(II) anticancer complexes.
    Adeniyi AA; Ajibade PA
    J Biomol Struct Dyn; 2014; 32(9):1351-65. PubMed ID: 23905613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational studies of the electronic, conductivities, and spectroscopic properties of hydrolysed Ru(II) anticancer complexes.
    Adeniyi AA; Ajibade PA
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():426-36. PubMed ID: 23867645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical study of the electronic and spectroscopic properties of some Ru(II) anticancer complexes.
    Adeniyi AA; Ajibade PA
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 105():456-65. PubMed ID: 23348198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes.
    Fernández R; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Chemistry; 2004 Oct; 10(20):5173-9. PubMed ID: 15372674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.
    Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
    Dalton Trans; 2012 Oct; 41(38):11608-18. PubMed ID: 22903512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution equilibria of anticancer ruthenium(II)-(η(6)-p-cymene)-hydroxy(thio)pyr(id)one complexes: impact of sulfur vs. oxygen donor systems on the speciation and bioactivity.
    Enyedy EA; Sija E; Jakusch T; Hartinger CG; Kandioller W; Keppler BK; Kiss T
    J Inorg Biochem; 2013 Oct; 127():161-8. PubMed ID: 23721887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the "piano-stool" [ruthenium(II) (eta6-arene)(en)CL]+ complexes with water and nucleobases; ab initio and DFT study.
    Futera Z; Klenko J; Sponer JE; Sponer J; Burda JV
    J Comput Chem; 2009 Sep; 30(12):1758-70. PubMed ID: 19090568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of oxygenation on the reactivity of ruthenium-thiolato bonds in arene anticancer complexes: insights from XAS and DFT.
    Sriskandakumar T; Petzold H; Bruijnincx PC; Habtemariam A; Sadler PJ; Kennepohl P
    J Am Chem Soc; 2009 Sep; 131(37):13355-61. PubMed ID: 19719101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
    Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory activities and possible anticancer targets of Ru(II)-based complexes using computational docking method.
    Adeniyi AA; Ajibade PA
    J Mol Graph Model; 2012 Sep; 38():60-9. PubMed ID: 23079641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Effects of Metals in a Promising Ru(II) -Pt(II) Assembly for a Combined Anticancer Approach: Theoretical Exploration of the Photophysical Properties.
    Alberto ME; Russo N; Adamo C
    Chemistry; 2016 Jun; 22(27):9162-8. PubMed ID: 27249166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoactivity of mono- and dicarbonyl complexes of ruthenium(II) bearing an N,N,S-donor ligand: role of ancillary ligands on the capacity of CO photorelease.
    Gonzalez MA; Carrington SJ; Chakraborty I; Olmstead MM; Mascharak PK
    Inorg Chem; 2013 Oct; 52(19):11320-31. PubMed ID: 24067067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared pigments based on ion-pair charge transfer salts of dicationic and dianionic metal-dithiolene [M(II) = Pd, Pt] complexes.
    Espa D; Pilia L; Marchiò L; Mercuri ML; Serpe A; Sessini E; Deplano P
    Dalton Trans; 2013 Sep; 42(34):12429-39. PubMed ID: 23863989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Density functional theory studies of interactions of ruthenium-arene complexes with base pair steps.
    Mutter ST; Platts JA
    J Phys Chem A; 2011 Oct; 115(41):11293-302. PubMed ID: 21812434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.
    Bratsos I; Simonin C; Zangrando E; Gianferrara T; Bergamo A; Alessio E
    Dalton Trans; 2011 Oct; 40(37):9533-43. PubMed ID: 21853191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Arene Ruthenium Antitumor Complexes.
    Su W; Tang Z; Li P
    Mini Rev Med Chem; 2016; 16(10):787-95. PubMed ID: 27161008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bidentate coordination on the molecular properties rapta-C based complex using theoretical approach.
    Adeniyi AA; Ajibade PA
    J Mol Model; 2013 Mar; 19(3):1325-38. PubMed ID: 23187687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of PPh₃ moiety in the anticancer activity of new organometallic ruthenium complexes.
    Sáez R; Lorenzo J; Prieto MJ; Font-Bardia M; Calvet T; Omeñaca N; Vilaseca M; Moreno V
    J Inorg Biochem; 2014 Jul; 136():1-12. PubMed ID: 24690555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.
    Gianferrara T; Bratsos I; Iengo E; Milani B; Ostrić A; Spagnul C; Zangrando E; Alessio E
    Dalton Trans; 2009 Dec; (48):10742-56. PubMed ID: 20023904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.